ID

23752

Descrizione

Study part: Adverse Events Week 20. A Phase 2 Multicenter, Double-blind, Placebo-controlled, Study to to Evaluate the Corticosteroid- sparing effects of Mepolizumab in Subjects with Hypereosinophilic Syndromes (HES) and Evaluate Efficacy and Safety of Mepolizumab in Controlling the Clinical Signs and Symptoms of subjects with HES Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Sponsor: GlaxoSmithKline. Study ID: 100185, Clinical Study ID:MHE100185.

Keywords

  1. 12/07/17 12/07/17 -
Titolare del copyright

GlaxoSmithKline

Caricato su

12 luglio 2017

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 3.0

Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Adverse Events Week 20 Mepolizumab HES NCT00086658

Adverse Events Week 20

  1. StudyEvent: ODM
    1. Adverse Events Week 20
ADVERSE EVENTS
Descrizione

ADVERSE EVENTS

Alias
UMLS CUI-1
C0877248
Any new study related non-serious adverse events/serious adverse events observed or reported by the subject or any changes to ongoing non-serious adverse events recorded in the appropriate Non-Serious Adverse Events/Serious Adverse Events section?
Descrizione

Adverse Events

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0877248

Similar models

Adverse Events Week 20

  1. StudyEvent: ODM
    1. Adverse Events Week 20
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
ADVERSE EVENTS
C0877248 (UMLS CUI-1)
Adverse Events
Item
Any new study related non-serious adverse events/serious adverse events observed or reported by the subject or any changes to ongoing non-serious adverse events recorded in the appropriate Non-Serious Adverse Events/Serious Adverse Events section?
boolean
C0877248 (UMLS CUI [1])

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial